{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-075736","form_type":"8-K","ticker":"SMNR","cik":"0001913577","company_name":"Semnur Pharmaceuticals, Inc.","filed_at":"2024-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.188520+00:00","generated_at":"2026-05-31T06:19:09.459918+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Denali SPAC enters $2.5B stock merger with Semnur Pharmaceuticals","bullets":["Equity value of $2.5B; consideration payable in Denali (New Semnur) common shares.","Scilex (Semnur parent) buys 500k Denali Class B shares for $2M cash and 300k Scilex shares.","Closing targeted for Q1 2025; subject to shareholder vote, HSR clearance, Nasdaq listing.","Sponsor and directors commit to vote for deal; Scilex signs stockholder support agreement.","Post-closing, Denali renamed Semnur Pharma; Scilex gets board designation rights."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-075736","json":"https://secwatch.observer/filing/0001213900-24-075736.json","markdown":"https://secwatch.observer/filing/0001213900-24-075736.md","text":"https://secwatch.observer/filing/0001213900-24-075736.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1913577/000121390024075736/0001213900-24-075736-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1913577/000121390024075736/ea0213186-8k425_denali.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:19:09.459918+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}